<DOC>
	<DOCNO>NCT00524030</DOCNO>
	<brief_summary>This study determine safety efficacy pregabalin ( Lyrica ) administer ( without anti-epileptic medication ) epilepsy subject treatment partial seizure . The duration trial 6 month .</brief_summary>
	<brief_title>Efficacy And Safety Study Of Pregabalin ( Lyrica ) As Monotherapy In Patients With Partial Seizures</brief_title>
	<detailed_description>After review interim analysis result , independent Data Monitoring Committee ( DMC ) recommend stop study base positive efficacy finding primary efficacy endpoint accord pre-specified stopping rule . Pfizer accept DMC recommendation make decision stop study September 7 , 2011 .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Diagnosis epilepsy partial seizure . Males female , age 18 year old . Documented history least 4 partial seizure 8 week prior screen visit . Stable treatment 1 2 antiepileptic drug 8 week prior screen visit . Current diagnosis febrile seizure seizures related ongoing acute medical event . Seizures occur cluster pattern , seizures metabolic , toxic infectious origin . Primary generalize epilepsy status epilepticus within previous year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>partial seizure</keyword>
	<keyword>pregabalin monotherapy</keyword>
	<keyword>double-blind randomize trial</keyword>
</DOC>